NCT07309991

Brief Summary

This study aims to determine whether postoperative hypoxia (arterial partial pressure of oxygen (PaO₂)\<80 mmHg) is an independent risk factor for anastomotic leakage after esophagectomy. The investigators conducted a retrospective analysis of cases from their center over the past five years, stratifying patients into Low Pa0₂ Group and Normal Pa0₂ Group based on postoperative oxygen levels and comparing the incidence of anastomotic leakage between the groups. The goal is to establish whether hypoxia is a causative risk factor and whether correcting it can reduce the risk of anastomotic leakage.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,500

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jan 2021Dec 2026

Study Start

First participant enrolled

January 1, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

December 16, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 30, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

4.9 years

First QC Date

December 16, 2025

Last Update Submit

June 13, 2026

Conditions

Keywords

Effect of Postoperative PaO₂ on Anastomotic Leakage Following Esophagectomy

Outcome Measures

Primary Outcomes (1)

  • Esophageal Anastomotic Leakage Rate

    Anastomotic leak was confirmed by either barium swallow study, CT scan, or endoscopy, or was clinically considered in cases with obvious salivary secretion from the cervical anastomosis. The esophageal anastomotic leakage rate was calculated as (the number of patients with a confirmed anastomotic leakage / the total number of patients who underwent esophagectomy) × 100%.

    From the date of surgery to 30 days postoperatively

Study Arms (2)

Low Pa02 Group

Patients were defined as belonging to the Low PaO₂ group if they exhibited at least one recorded instance of PaO₂ \<80 mmHg within the first postoperative week.

Normal PaO2 Group

Patients maintained a PaO₂ ≥80 mmHg throughout the first postoperative week.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This retrospective cohort study included patients diagnosed with esophageal carcinoma or benign esophageal tumors who required surgical resection of the lesion followed by esophageal reconstruction. All patients had at least one postoperative arterial blood gas analysis, and anastomotic healing was assessed via esophagram, CT scan, endoscopy, or typical clinical sign.

You may qualify if:

  • Patients diagnosed with esophageal carcinoma or benign esophageal tumors
  • Patients requiring surgical resection of the lesion with subsequent esophageal reconstruction
  • Patients must have had at least one postoperative arterial blood gas analysis
  • Patients must have routinely undergone at least one of the following for postoperative evaluation of the anastomosis: endoscopy, CT scan, or esophagram

You may not qualify if:

  • Patients who did not require esophageal reconstruction
  • Patients undergoing esophageal replacement with colon
  • Patients with incomplete data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Department of Thoracic Surgery, Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, 510060, China

RECRUITING

Cancer Hospital of Shantou University Medical College

Shantou, Guangdong, China

RECRUITING

The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital

Shijiazhuang, Hebei, China

RECRUITING

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China

RECRUITING

Sichuan Cancer Hospital

Chengdu, Sichuan, China

RECRUITING

0817-2598459

Nanchong, Sichuan, China

RECRUITING

MeSH Terms

Conditions

Esophageal NeoplasmsAdenocarcinoma Of Esophagus

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Study Officials

  • Hong Yang, M.D.

    Department of Thoracic Surgery, Sun Yat-sen University Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yizhang Chen, M.D. candidate

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 16, 2025

First Posted

December 30, 2025

Study Start

January 1, 2021

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

June 16, 2026

Record last verified: 2026-06

Locations